1. Home
  2. CASI vs GTIM Comparison

CASI vs GTIM Comparison

Compare CASI & GTIM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CASI
  • GTIM
  • Stock Information
  • Founded
  • CASI 1991
  • GTIM 1987
  • Country
  • CASI China
  • GTIM United States
  • Employees
  • CASI N/A
  • GTIM N/A
  • Industry
  • CASI Biotechnology: Pharmaceutical Preparations
  • GTIM Restaurants
  • Sector
  • CASI Health Care
  • GTIM Consumer Discretionary
  • Exchange
  • CASI Nasdaq
  • GTIM Nasdaq
  • Market Cap
  • CASI 20.5M
  • GTIM 17.1M
  • IPO Year
  • CASI 1996
  • GTIM 1990
  • Fundamental
  • Price
  • CASI $2.36
  • GTIM $1.73
  • Analyst Decision
  • CASI Strong Buy
  • GTIM
  • Analyst Count
  • CASI 1
  • GTIM 0
  • Target Price
  • CASI $4.00
  • GTIM N/A
  • AVG Volume (30 Days)
  • CASI 3.7M
  • GTIM 34.9K
  • Earning Date
  • CASI 09-02-2025
  • GTIM 08-07-2025
  • Dividend Yield
  • CASI N/A
  • GTIM N/A
  • EPS Growth
  • CASI N/A
  • GTIM 17.03
  • EPS
  • CASI N/A
  • GTIM 0.12
  • Revenue
  • CASI $31,368,000.00
  • GTIM $143,398,000.00
  • Revenue This Year
  • CASI N/A
  • GTIM N/A
  • Revenue Next Year
  • CASI N/A
  • GTIM N/A
  • P/E Ratio
  • CASI N/A
  • GTIM $14.67
  • Revenue Growth
  • CASI 8.39
  • GTIM 1.78
  • 52 Week Low
  • CASI $1.09
  • GTIM $1.34
  • 52 Week High
  • CASI $7.67
  • GTIM $3.45
  • Technical
  • Relative Strength Index (RSI)
  • CASI 64.70
  • GTIM 59.37
  • Support Level
  • CASI $1.95
  • GTIM $1.69
  • Resistance Level
  • CASI $3.09
  • GTIM $1.84
  • Average True Range (ATR)
  • CASI 0.34
  • GTIM 0.10
  • MACD
  • CASI 0.07
  • GTIM 0.03
  • Stochastic Oscillator
  • CASI 55.21
  • GTIM 78.00

About CASI CASI Pharmaceuticals Inc.

CASI Pharmaceuticals Inc is a biopharmaceutical company that focuses on commercializing therapeutics and pharmaceutical products. The products include injections for patients who are suffering from leukemias and lymphomas. The EVOMELA injection is used as a conditioning treatment before autologous stem cell transplant for patients with multiple myeloma. The company products include CID-103, CNCT19, EVOMELA, MARQIBO, ZEVALIN, ENMD-2076 and others. The majority of the revenue is generated from the product sales of EVOMELA.

About GTIM Good Times Restaurants Inc.

Good Times Restaurants Inc is engaged in developing, owning, operating, and franchising hamburger-oriented drive-through restaurants. It operates through two segments: Good Times Burgers and Frozen Custard restaurants which operate in the quick-service drive-through dining industry; and Bad Daddy's Burger Bar restaurants which operate in the full-service upscale casual dining industry. The company generates maximum revenue from the Bad Daddy's Burger Bar restaurants segment. Its menu categories include burgers; chicken; frozen custard; slides and drinks.

Share on Social Networks: